Reducing the GI Risks of Antiplatelet Therapy and NSAID Use
-
There is uncertainty about how to best prevent bleeding complications in patients receiving antiplatelet therapy and NSAIDs.
-
Patients are on these agents for longer periods than in the past, increasing their time of risk.
-
Evaluation of the risk profile for each patient is critical.
Supporting Materials
Editorial | Use of Nonsteroidal Antiinflammatory Drugs - An Update for Clinicians | Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents |Cardiology Patient Page: Can Patients With Cardiovascular Disease Take Nonsteroidal Antiinflammatory Drugs?
